Volume 10, Issue 6 (4-2012)                   IJRM 2012, 10(6): 589-594 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zhang Q, Xia L, Jing G. A new effective method in the treatment of severe ovarian hyperstimulation syndrome. IJRM 2012; 10 (6) :589-594
URL: http://ijrm.ir/article-1-322-en.html
A new effective method in the treatment of severe ovarian hyperstimulation syndrome
Qingrui Zhang1 , Liangbin Xia * 2, Gao Jing1
1- Department of Gynecology, Renmin Hospital of Wuhan University, Wuhan, China
2- Department of Gynecology, Renmin Hospital of Wuhan University, Wuhan, China , Xialiangbin@hotmail.com
Abstract:   (5100 Views)
Background: Ovarian hyperstimulation syndrome (OHSS) is a recognized complication of ovulation induction, occurring in 1-10% of IVF and embryo transfer cycles. While mild OHSS is of no clinical relevance, severe OHSS is a life threatening complication. However, the efficacy of prevalent treatments appeared to be limited. We developed a continuous autotransfusion system with an ultrafiltration instrument for reinfusion the protein of concentrated ascites for the treatment of severe OHSS.
Objective: To study the efficacy and safety of using a continuous autotransfusion system for the treatment of severe OHSS.
Materials and Methods: 69 patients with severe OHSS who were treated with controlled ovarian hyperstimulation due to infertility from February 2002 to August 2010 in our reproductive center were divided into two groups. One group treated with continuous autotransfusion system with an ultrafiltration instrument which infused the protein of concentrated ascites, called ultrafiltration group, another group were treated with simple-albumin supplement, called albumin group. Several examinational results and adverse effect were compared between the two groups.
Results: The volume of urine output after 72h in ultrafiltration group was more than that in albumin group, the waist circumference and body weight in ultrafiltration group were lower than those in albumin group after 72h. The serum creatinine levels after 72h in ultrafiltration group was still significantly lower than that in albumin group (p<0.05). The ultrafiltration group rarely showed adverse effect compared with albumin group.
Conclusion: Autotransfusion of protein in concentrated ascites for the treatment of severe ovarian hyperstimulation syndrome was effective and safe.
Keywords: OHSS, Infertility, Ascites, Transfusion
Full-Text [PDF 214 kb]   (661 Downloads) |   |   Full-Text (HTML)  (388 Views)  
Type of Study: Original Article |
References
1. Abuzeid MI, Nassar Z, Massaad Z, Weiss M, Ashraf M, Fakih M. Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 2003; 18: 370-373. [DOI:10.1093/humrep/deg074]
2. Kumar P，Sait SF，Sharma A，Kumar M. Ovarian hyperstimulation syndrome. Hum Reprod 2011; 4: 70-75. [DOI:10.4103/0974-1208.86080]
3. Hock DL, Seifer DB. Ovarian hyperstimulation syndrome. Infertil Reprod Med Clin North AM 2000; 399-417.
4. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992; 58: 249-261. [DOI:10.1016/S0015-0282(16)55188-7]
5. Manaka C, Araki S, Motoyama M. Management of ovarian hyperstimulation syndrome (in Japanese). Jpn J Fertil Steril 1995; 40: 427-432.
6. Balasch J, Fabregues F, Arroyo V. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet Gynecol Scand 1996; 75: 662-667. [DOI:10.3109/00016349609054694]
7. Brinsden PI, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102: 767-772. [DOI:10.1111/j.1471-0528.1995.tb10840.x]
8. Ferraretti AP, Gianaroli L, Diotallevi L, Festi C, Trounson A. Dopamine treatment for severe ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 180-183. [DOI:10.1093/oxfordjournals.humrep.a137613]
9. Al-Shawaf T, Grudzinskas JG. Prevention and treatment of ovarian hyperstimulation syndrome. Best Pract Res Clin Obstet Gynaecol 2003; 17: 249-261. [DOI:10.1016/S1521-6934(02)00127-X]
10. Toshimitsu K, Shigeo A, Hisanori M，Shuichi O, Masaaki S, Hiroaki S, et al. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 2000; 15: 113-117. [DOI:10.1093/humrep/15.1.113]
11. Friedman CI, Schmidt GE, Chang FE. Severe ovarian hyperstimulation following follicular aspiration. Am J Obstet Gynecol 1984; 150: 436-437. [DOI:10.1016/S0002-9378(84)80158-1]
12. Aflatoonian A, Ghandi S, Tabibnejad N. Comparison of coasting with Cabergoline administration for prevention of early severe OHSS in ART cycles. Iran J Reprod Med 2008; 6: 51-55.
13. Annick D, Corinne C, Serge R. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle. Fertil Steril 2001; 76: 844-846. [DOI:10.1016/S0015-0282(01)02007-6]
14. Endo T, Kitajima Y, Hayashi T, Fujii M, Hata H, Azumaguchi A. Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion. Fertil Steril 2004; 82:1449-1451. [DOI:10.1016/j.fertnstert.2004.04.045]
15. Chan CC, Yin CS, Lan SC, Chen IC, Wu GJ. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome. J Chin Med Assoc 2004; 67: 197-199.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb